Why Trulieve Cannabis Skyrocketed 14.1% Today

Shares of Trulieve Cannabis (OTC: TCNNF) jumped 14.1% after President Trump said his administration is considering reclassifying marijuana to Schedule III, a policy shift that would materially change federal regulatory and tax treatment of cannabis. Trulieve—one of the few U.S. operators reporting pre-tax profitability due to its dominant position in Florida’s medical market—would likely see a meaningful reduction in tax burden and an immediate boost to cash flow if reclassification occurs, but timing and certainty remain unclear and the stock is likely to stay volatile until policy is formalized.

Analysis

President Trump confirmed his administration is considering reclassifying marijuana to Schedule III, saying "a lot of people want to see it," and that announcement triggered a 14.1% intraday rally in Trulieve Cannabis (OTC: TCNNF) while the S&P 500 fell 0.3% and the Nasdaq Composite rose 0.2%. The market response indicates investors are re-pricing companies with meaningful U.S. operational exposure to potential federal regulatory relief. Trulieve is highlighted in the article as one of the few U.S. cannabis operators reporting pre-tax profitability, driven by its dominant position in Florida’s medical-marijuana market, which would make it an immediate beneficiary of any tax and regulatory easing. Reclassification to Schedule III would materially reduce Trulieve’s federal tax burden and likely improve cash flow and near-term earnings, but the article stresses there is no certainty the policy change will occur and that the stock will remain volatile until regulatory clarity is achieved.

The Motley Fool note also flags that Trulieve was not included in its Stock Advisor top-10 picks and discloses no position by the author or Motley Fool, underscoring divergent analyst views and the promotional context in which the rally was discussed. Given the article’s characterization, the current rally reflects event-driven repositioning rather than new company-specific operational news, so gains could reverse on any setback or slow-moving regulatory process. Sentiment indicators in the accompanying signals are moderately positive (sentiment_score 0.48, market_impact_score 0.5), consistent with a speculative yet potentially high-impact policy scenario that merits active monitoring rather than passive buy-and-hold allocation.

Key Decisions for Investors

• Consider establishing a modest, risk-sized long position in Trulieve to capture upside from potential reclassification while explicitly sizing for high volatility and event risk
• Avoid large, permanent allocations until formal rule-making or legislative action clarifies timing and scope of Schedule III reclassification
• Monitor developments closely around federal regulatory notices, IRS/DEA guidance and Trulieve's next quarterly tax-rate and cash-flow disclosures and use options or stop-loss limits to hedge short-term exposure